When a second xenograft model based on the Bcl-6 independent diffuse large B-cell lymphoma (DLBCL) Toledo cell line was tested, application of the 79-6 inhibitor comparably did not enhance tumor growth (data not shown). The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.